Eric J Chow, MD, MPH

Eric J Chow, MD, MPH

Specialties

"My goal is not just to improve cure rates for childhood cancer, but to improve the quality of life for children and families dealing with and successfully overcoming cancer."
  • Biography

    Eric Chow, MD, MPH, is an attending physician at Seattle Childrens Hospital, associate professor of pediatrics at the University of Washington School of Medicine, and associate professor with the Clinical Research and Public Health Sciences Divisions at the Fred Hutchinson Cancer Center. His clinical and research interests focus on cancer survivorship, and he is the medical director of the Cancer Survivor Program at Seattle Children's (http://seattlechildrens.org/cancersurvivorprogram).

    Together with other members of the Cancer and Blood Disorders Center, the goal of the cancer survivor program is to enhance patient and family awareness of potential cancer therapy-related late effects, and to maximize quality of life by early detection and treatment of these late effects. Dr. Chow's current research attempts to better understand risk factors that contribute to increased metabolic and cardiovascular complications following cancer therapy, with studies examining glucocorticoid pharmacogenetics in relation to obesity following leukemia therapy, treatment and genetic factors that contribute to cardiovascular toxicity following hematopoietic cell transplantation, and application of population-based databases to study cancer late effects. Related to these interests, Dr. Chow holds leadership positions within the Childrens Oncology Group's Outcomes and Survivorship Committee and the National Cancer Institute-sponsored Childhood Cancer Survivor Study.

    Board Certification(s)

    Pediatric Hematology-Oncology

    Education

    University of California Berkeley-School of Public Health, Berkeley, CA
    University of California San Francisco School of Medicine, San Francisco, CA

    Residency

    University of Washington School of Medicine, Seattle, WA

    Fellowship

    Fred Hutchinson Cancer Center, Seattle, WA

    Clinical Interests

    Cancer survivorship, late effects after cancer and hematopoietic cell transplantation

    Research Description

    I am a pediatric oncologist and epidemiologist whose research focuses on cancer survivorship. My group is interested in better understanding the burden and risk factors for cardiovascular outcomes following childhood cancer therapy and stem cell transplantation. To this end, we utilize data from medical records as well as prospectively bring patients back to clinic for various physiologic measurements. Our survivorship research also includes work examining various gene polymorphisms of interest and data linkage strategies utilizing large public databases. Finally, we also design clinical trials to test strategies that help survivors lead healthier lives after cancer, focused on improving lifestyles and care coordination with primary care. 

    Research Focus Area

    Cancer, Chronic Conditions / Special Health Care Needs, Epidemiology, Stem Cell Transplantation

  • Related Resources

  • Patient Testimonials

    • {{ testimonial.displayName }}
      {{ testimonial.location }}
      {{ formatTestimonialDate(testimonial.date) }}

      {{ testimonial.testimony }}

  • Awards and Honors

    Award Name Award Description Awarded By Award Date
    {{ award.name }} {{ award.description }} {{ award.organization }} {{ award.displayDate }}
  • Publications

  • Presentations

    Presentation Title Event Location Date
    {{ presentation.title }} {{ presentation.presentedAt }} {{ presentation.location }} {{ presentation.displayDate }}
  • Research Funding

    Grant Title Grantor Amount Award Date
    {{ funding.title }} {{ funding.grantedBy }} {{ funding.amount }} {{ funding.displayDate }}
  • Clinical Trials and Research

    {{ item.t }}

    {{ item.st }}

    {{ item.obj }}

    Condition(s): {{ item.con }} Phase: {{ item.ph }} Clinicaltrials.gov ID: {{ item.nct }}

    No clinical trials found for Eric J Chow, MD, MPH.